-
阿加曲班杂质43
- names:
Argatroban Impurity 43
- CAS号:
121785-71-5
MDL Number: - MF(分子式): C23H36N6O5S MW(分子量): 508.63
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YPZZ61411-10mg | 10mg | 0.98 | ¥ 0.00 | ¥ 0.00 | Get quote | ¥ 0.00 |
| 中文别名 | 阿夫唑嗪杂质;阿呋唑嗪杂质;滞剂阿夫唑嗪杂质;盐酸阿夫唑嗪杂质 |
| 英文别名 | (2R,4R)-1-((S)-5-guanidino-2-((R)-3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonamido)pentanoyl)-4-methylpiperidine-2-carboxylic acid |
| CAS号 | 121785-71-5 |
| Inchi | InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15?,17+,18-/m1/s1CopyCopied |
| InchiKey | KXNPVXPOPUZYGB-IOVMHBDKSA-NCopyCopied |
| 分子式 Formula | C23H36N6O5S |
| 分子量 Molecular Weight | 508.63 |
| 溶解度Solubility | |
| 性状 | |
| 储藏条件 Storage conditions |
杂质产品注意事项:1、普通杂质产品需要提供核磁[氢谱、碳谱(如氢谱不能证明该化合物的情况下)]、LC-MS图谱、色谱图、手性化合物需要核磁二维图谱表征。
| 产品说明 | 阿加曲班杂质43是合成阿加曲班过程中产生多余的化学物质它会与药物活性成分(API)一起保留,这些有害化学物质的存在,可能影响药品的功效和安全性。 |
| Introduction | Argatroban Impurity 43 is a impurity of Argatroban . It will remain with the active pharmaceutical ingredients (API). The presence of these harmful chemicals may affect the efficacy and safety of the drug. |
| Application1 | |
| Application2 | |
| Application3 |
| 警示图 | |
| 危险性 | |
| 危险性警示 | 暂无数据 |
| 安全声明 | CAUTION: May irritate eyes, skin |
| 安全防护 | |
| 备注 |
| A Finding of Highly Selective Synthetic Inhibitor of Plasma Kallikrein; Its Action to Bradykinin Generation, Intrinsic Coagulation and Experimental DIC,Recent Progress on Kinins[DOI: 10.1007978-3-0348-7321-5_26] |
| Argatroban as an alternative anticoagulant for patients with heparin allergy during coronary bypass surgery,Heart and Vessels[DOI: 10.1007s003800300006] |
| Quantitation of Argatroban in Plasma Using Liquid Chromatography Electrospray Tandem Mass Spectrometry (UPLC-ESI-MSMS),Clinical Applications of Mass Spectrometry[DOI: 10.1007978-1-60761-459-3_6] |
| Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models,Intracranial Pressure and Brain Monitoring XII[DOI: 10.10073-211-32318-X_82] |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


